The peculiar autoimmunity of primary biliary cirrhosis

Immunological Reviews

Volumn 174, Issue , 2000, Pages 226-237

  Mackay, Ian R ^a   Whittingham, Senga ^a   Fida, Shahnaz ^a   Myers, Mark ^a   Ikuno, Nobuhiro ^a   Gershwin, M Eric ^b   Rowley, Merrill J ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOACID DEHYDROGENASE; AUTOANTIBODY; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; DNA BINDING PROTEIN; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; PEPTIDE LIBRARY; PYRUVATE DEHYDROGENASE COMPLEX;

ADULT; AUTOIMMUNITY; DISEASE ASSOCIATION; ENZYME MECHANISM; EPITOPE MAPPING; FEMALE; GENETIC TRANSCRIPTION; HASHIMOTO DISEASE; HISTOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; INFLAMMATORY INFILTRATE; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR CLONING; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SEROLOGY; SJOEGREN SYNDROME; STRUCTURE ANALYSIS; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ACYLTRANSFERASES; ADULT; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CELL NUCLEUS; CENTROMERE; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; EPITOPES; FEMALE; HIGH MOBILITY GROUP PROTEINS; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PEPTIDES; PREVALENCE; PYRUVATE DEHYDROGENASE COMPLEX; SEX DISTRIBUTION;

EID: 0034085812     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.017410.x     Document Type: Review

References (65)

1. 1. Gershwin ME, Mackay IR. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 1991;100:822-833.
2. 2. Gershwin ME, Mackay I, Coppel R, Nakanuma Y. Clinical, immunologic and molecular features of primay biliary cirrhosis. Semin Clin Immunol 1994;7:5-16.
3. 3. Mackay IR. Primary biliary cirrhosis showing a high titer of autoantibody. N Engl J Med 1958;258:185-187.
4. 4. Walker JG, Doniach D, Roitt IM, Sherlock S. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1965;i:827-831.
5. 5. Berg PA, Klein R. Mitochondrial antigen/antibody system in primary biliary cirrhosis: revisited. Liver 1995;15:281-292.
6. 6. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kD mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987;138:3525-3531.
7. 7. Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis. Am J Pathol 1965;46:387-407.
8. 8. Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology 1999;29:644-647.
9. 9. Poupon RE, Bonnand AM, Chretien Y. The UDCA-PBC Study Group. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Hepatology 1999;29:1668-1671.
10. 10. Crosignani A, Podda M, Battezzati PM. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology 1991;14:1000-1007.
11. 11. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997;25:1077-1084.
12. 12. Yoshikawa M, Tsujii T, Matsumura K, Kubo R, Fukui H, Ishizaka S. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992;16:358-364.
13. 13. Terasaki S, Nakanuma Y, Ogino H, Unoura M, Kobayashi K. Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy. Am J Gastroenterol 1991;86:1194-1199.
14. 14. Guldutuna S, Zimmer G, Imhof M, Bhatti S, You T, Leuschner U. Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology 1993;104:1736-1744.
15. 15. Yamazaki K, et al. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 1999;30:71-78.
16. 16. Parikh-Patel A, Gold E, Mackay IR, Gershwin ME. The geoepidemiology of primary biliary cirrhosis: contrasts and comparisons with the spectrum of autoimmune diseases. Clin Immunol 1999;91:206-218.
17. 17. Gershwin ME, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000;174:210-225.
18. 18. Mackay IR, Gershwin ME. Primary biliary cirrhosis. In: Karawitt EL, Wiesner RH, Nishioka M, eds. Autoimmune liver diseases. Amsterdam: Elsevier; 1998. p. 49-69.
19. 19. Caldwell SH, et al. Antimitochondrial antibodies in kindreds of patients with PBC, AMA are unique to clinical disease and are absent in asymptomatic family members. Hepatology 1992;16:899-905.
20. 20. Mackay IR. Autoimmune disease overlaps and the liver: two for price of one? J Gastroenterol Hepatol (In press).
21. 21. Bassendine MF, Jones DEJ. Antimitochondrial and other autoantibodies in primary biliary cirrhosis. In: Krawitt EL, Wiesner RH, Nishioka M, eds. Autoimmune liver diseases. 2nd ed. Amsterdam: Elsevier; 1998. p. 287-304.
22. 22. Surh CD, et al. The predominance of IgG3 and IgM isotype antimitochondrial antibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology 1988;8:290-295.
23. 23. Kinoshita H, Omagari K, Matsuo I, Yamaguchi K, Ikuno N, Kohno S. Frequency of IgG, IgM and IgA class autoantibodies against 2-oxo-acid dehydrogenase complex in 102 Japanese patients with primary biliary cirrhosis. Hepatol Res 1999;15:163-171.
24. 24. Zhang L, Weetman AP, Jayne DRW, Yeaman SJ, Bassendine MF, Oliveira DBG. Antimitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis. Clin Exp Immunol 1992;88:56-61.
25. 25. Outschoorn I, Rowley MJ, Cook AD, Mackay IR. Subclasses of immunoglobulins and autoantibodies in autoimmune diseases. Clin Immunol Immunopathol 1993;66:59-66.
26. 26. Jois J, Omagari K, Rowley MJ, Mackay IR. Enzyme inhibitory antibody to pyruvate dehydrogenase: diagnostic utility in primary biliary cirrhosis. Ann Clin Biochem (In press).
27. 27. Teoh K-L, Mackay IR, Rowley MJ, Fussey SPM. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology 1994;19:1029-1033.
28. 28. Hooper B, Whittingham S, Mathews JD, Mackay IR, Curnow DH. Autoimmunity in a rural community. Clin Exp Immunol 1972;12:79-87.
29. 29. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OFW. Natural history of early primary biliary cirrhosis. Lancet 1996;348:1399-1402.
30. 30. Chen Q-Y, Mackay IR, Fida S, Myers MA, Rowley MJ. Natural and disease-associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognise different epitopes. J Autoimmun 1998;11:51-161.
31. 31. Rowley MJ, et al. Differing epitope selection of experimentally induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex. Int Immunol 1992;4:1245-1253.
32. 32. Palmer JM, Jones DEJ, Quinn J, McHugh A, Yeaman SJ. Characterization of the autoantibody responses to recombinant E3 binding protein (protein x) of pyruvate dehydrogenase in primary biliary cirrhosis. Hepatology 1999;30:21-26.
33. 33. Underwood JR, Pedersen J, Chalmers PJ, Toh B-H. Hybrids from normal, germ-free nude and neonatal mice produce monoclonal antibodies to eight different intracellular structures. Clin Exp Immunol 1985;60:417-426.
34. 34. Mu F-T, Alderuccio F, Toh B-H, Gershwin ME, Coppel R, Mackay IR. Murine monoclonal antibody to michondria reacts with the 72 kD antigen of primary biliary cirrhosis. Clin Exp Immunol 1988;71:100-106.
35. 35. Leung PSC, Coppel RL, Ansari A, Munoz S, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:61-69.
36. 36. Tsuneyama K, et al. Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry. Autoimmunity 1997;26:23-31.
37. 37. Thomson RK, et al. Immunogenetic analysis of a panel of monoclonal IgG and IgM anti-PDC-E2/X antibodies derived from patients with primary biliary cirrhosis. J Hepatol 1998;28:582-594.
38. 38. Krams SM, Surh CD, Coppel RL, Ansari A, Ruebner B, Gershwin ME. Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis. Hepatology 1989;9:411-436.
39. 39. Rowley MJ, McNeilage LJ, Armstrong JM, Mackay IR. Inhibitory antibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primary biliary cirrhosis. Clin Immunol Immunopathol 1991;60:356-370.
40. 40. Waisman A, Medlovic S, Ruiz PJ, Meshorer A, Mozes I. The role of the 16/6 idiotype network in the induction and manifestation of systemic lupus erythematosus. Int Immunol 1993;5:1293-1300.
41. 41. Chen Q-Y, Rowley MJ, Mackay IR. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects. Hepatology 1999;29:624-631.
42. 42. Wands JR, Dienstag JL, Bhan AK, Feller ER, Isselbacher KJ. Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med 1978;298:233-237.
43. 43. Mackay IR, Rowley MJ, Whittingham S. Nuclear antibodies in primary biliary cirrhosis. In: Meyer zum Buschenfelde K-H, Hoofnagle J, Manns M, eds. Immunology and liver. Falk Symposium 70. Dordrecht: Kluwer; 1993. p. 379-409.
44. 44. Kinoshita H, et al. Autoimmune cholangitis and primary biliary cirrhosis - an autoimmune enigma. Liver 1999;14:122-128.
45. 45. Saitoh H, et al. CENP-C, an autoantigen in scleroderma is a component of the human inner kinetochore plate. Cell 1992;70:115-125.
46. 46. Parveen S, Morshed SA, Nishioka M. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities. J Gastroenterol Hepatol 1995;10:438-445.
47. 47. Whyte J, Hough D, Maddison PJ, McHugh NJ. The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens. J Autoimmun 1994;7:413-124.
48. 48. Courvalin J-C, Worman H. Nuclear and envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:79-88.
49. 49. Wisierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J Exp Med 1995;182:1159-1162.
50. 50. Szostecki C, Guldner HH, Will H. Autoantibodies against nuclear dots in primary biliary cirrhosis. Semin Liver Dis 1997;17:71-78.
51. 51. Sternsdorf T, Jensen K, Reich B, Will H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization and modification by small ubiquitin-like modifiers. J Biol Chem 1999;274:12555-12566.
52. 52. Blüthner M, Schäfer C, Schneider C, Bautz FA. Identification of major linear epitopes on the sp100 nuclear PBC autoantigen by the gene-fragment phage-display technology. Autoimmunity 1999;29:33-42.
53. 53. Rabin DJ, Pleasic SM, Palmer-Crocker R, Shapiro JA. Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992;41:183-186.
54. 54. Kasimiotis H, et al. The SRY-related protein, SOX13, is a diabetes autoantigen expressed in pancreatic islets. Diabetes (In press).
55. 55. Yamashita A, et al. CDNA cloning of a novel rainbow trout SRY-type HMG domain protein, rtSOX23, and its functional analysis. Gene 1998;209:193-200.
56. 56. Van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL. The autoepitope of the 74 Kd mitochondrial autoamigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1998;67:1791-1799.
57. 57. Fussey SMP, Ali ST, Guest JR, James OFW, Bassendine MF, Yeaman SJ. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci USA 1990;87:3987-3991.
58. 58. Koike K, Ishibashi H, Koike M. Immunoreactivity of porcine heart dihydrolipoamide acetyl-and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterization of the autoantigenic region and effects of enzymatic delipoylation and relipoylation. Hepatology 1998;27:1467-1474.
59. 59. Hannum CH, Utlee M, Matis LA, Schwartz RH, Margoliash E. The major B and T cell determinant on pigeon cytochrome c in B10.a mice. Adv Exp Med Biol 1982;150:37-51.
60. 60. Mackay IR, Davies JM, Rowley MJ. Towards the pathogenesis of autoimmune liver disease. J Autoimmun 1999;13:163-169.
61. 61. Howard MJ, et al. Three-dimensional structure of the major autoantigen in primary biliary cirrhosis. Gastroenterology 1998;115:139-146.
62. 62. Rowley MJ, et al. Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex-E2 (PDC-E2) in primary biliary cirrhosis using phage display. J Immunol (In press).
63. 63. Cha S, et al. Random phage mimotopes recognized by monoclonal antibodies against the pyruvate dehydrogenase complex-E2 (PDC-E2). Proc Natl Acad Sci USA 1996;93:10949-10954.
64. 64. Leung PSC, et al. Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes. J Autoimmun 1996;9:785-793.
65. 65. Horsfall AC, Hay FC, Soltys AJ, Jones MG. Epitope mapping. Immunol Today 1991;12:211-213.